Evidence is provided that a single intranasal dose of LMNSC01 can reprogram chronic neuroimmune and neurovascular dysfunction after TBI in both sexes and supports the translational development of non-invasive intranasal LMNSC01 therapy for TBI.
Brecken Enright, Jeffrey P. Cheng, V. Adhikarla et al.· bioRxiv· 0 citations
Background Pediatric and adult brain tumors, including glioblastoma, astrocytoma, ependymoma, and medulloblastoma, remain associated with poor prognosis despite advances in surgery, radiation, and chemotherapy. Therapeutic resistance, tumor heterogeneity, and treatment-related toxicity highlight the need for clinically...
Margarita Gutova, Eric Ma, H. Natri et al.· bioRxiv· 0 citations
Background/Objectives Cancer survivors frequently experience long-term neurocognitive impairments following chemotherapy and cranial irradiation, yet experimental models that enable mechanistic investigation of therapy-induced neurotoxicity at the transcriptional level remain limited. This study aimed to develop a huma...
Lance G. A. Nunes, Isabella Vasquez, Brecken Enright et al.· bioRxiv· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.